| __timestamp | BioMarin Pharmaceutical Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 461543000 | 5280000 |
| Thursday, January 1, 2015 | 634806000 | 7148000 |
| Friday, January 1, 2016 | 661905000 | 19594000 |
| Sunday, January 1, 2017 | 610753000 | 22894000 |
| Monday, January 1, 2018 | 696328000 | 50337000 |
| Tuesday, January 1, 2019 | 715007000 | 109450000 |
| Wednesday, January 1, 2020 | 628116000 | 90450000 |
| Friday, January 1, 2021 | 628793000 | 104128000 |
| Saturday, January 1, 2022 | 649606000 | 108630000 |
| Sunday, January 1, 2023 | 746773000 | 134951000 |
Unleashing the power of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
BioMarin has consistently increased its R&D expenses, with a notable 62% rise from 2014 to 2023. This growth underscores BioMarin's dedication to advancing its pipeline of therapies, particularly in rare genetic diseases.
In contrast, Rhythm Pharmaceuticals has shown a remarkable surge in R&D spending, skyrocketing by over 2,400% during the same period. This dramatic increase reflects Rhythm's aggressive strategy to develop treatments for rare genetic disorders related to obesity.
These trends highlight the dynamic nature of the biotech industry, where strategic R&D investments can pave the way for groundbreaking medical advancements.
Research and Development Expenses Breakdown: Novartis AG vs BioMarin Pharmaceutical Inc.
R&D Insights: How Bristol-Myers Squibb Company and BioMarin Pharmaceutical Inc. Allocate Funds
Comparing Innovation Spending: Zoetis Inc. and BioMarin Pharmaceutical Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.
United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
BioMarin Pharmaceutical Inc. or Pharming Group N.V.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: CymaBay Therapeutics, Inc. vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Rhythm Pharmaceuticals, Inc. and Galapagos NV